Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neoplasm Metastasis × Biological Therapy × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 2 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Myeloid, Acute 1 Leukemia, Monocytic, Acute 1 Leukemia, Megakaryoblastic, Acute 1 Leukemia, Erythroblastic, Acute 1 Congenital Abnormalities 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Gemcitabine 62 Capecitabine 57 Paclitaxel 53 Fluorouracil 51 Oxaliplatin 50 Bevacizumab 48 Leucovorin 44 Docetaxel 41 Nivolumab 38 Carboplatin 35 Cisplatin 34 Irinotecan 33 pembrolizumab 28 Cetuximab 28 Trastuzumab 27 Radiosurgery 26 Radiotherapy 23 Everolimus 21 Sorafenib 18 Pemetrexed 17 Panitumumab 17 Cyclophosphamide 17 Prednisone 16 Ipilimumab 16 Erlotinib Hydrochloride 16 Doxorubicin 16 Albumin-Bound Paclitaxel 16 Lapatinib 15 Zoledronic Acid 14 pazopanib 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07111104 2025-08-08

ARIS

Hopitaux Prives de Metz, Groupe UNEOS

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡